过往新闻 FDA Breakthrough Devices Designation application to fast-track painful finger-prick alternative for people living with diabetes December 13, 2021 Market Announcement – The iQ Group Globa… Read More → Validation study showcases success of LSBD’s rapid SARS-CoV-2 Antibody test November 11, 2021 Market Announcement – The iQ Group Globa… Read More → Gold Technology for Immune Response Cancer Therapy Licensed to OncoTEX November 4, 2021 OncoTEX Inc. (OncoTEX), a US oncology co… Read More → 国际报道 Making the Medicines of the Future: Dr George Syrmalis Dr George Syrmalis interview: ‘Calls for biotech investment rethink’ Scope for Saliva to Replace Blood in Diabetes Monitoring The iQ Group Global Introduces the Saliva Glucose Biosensor The iQ Group Global Developing Saliva-Based Glucose Test The iQ Group Global acquires new anticancer drug platform from University of Texas 媒体联络 与下面的我们的媒体代表联系。 AustraliaJames Gorman+61 2 8239 5400james.gorman@theiqgroupglobal.commedia@theiqgroupglobal.com
